Study of the Relationship between ERCC1 Polymorphisms and Response to Platinum-based Chemotherapy in Iranian Patients with Colorectal and Gastric Cancers

This study was designed to evaluate the effect of excision repair cross complementing group 1 (ERCC1) rs11615 codon 118C/T gene polymorphisms on treatment outcomes in Iranian patients receiving oxaliplatin-based regimens for colorectal (CRC) and gastric cancers (GC). Patients, who were candidates to...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Iran J Pharm Res
Autores principales: Abyarghamsari, Mahdiye, Hosseini Shirazi, Farshad, Tavakoli-Ardakani, Maria, Rezvani, Hamid, Mirzaei, Hamid Reza, Salamzadeh, Jamshid
Formato: Artigo
Lenguaje:Inglês
Publicado: Shaheed Beheshti University of Medical Sciences 2019
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7059040/
https://ncbi.nlm.nih.gov/pubmed/32184881
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22037/ijpr.2019.1100827
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares